NCT01332565View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG

GSK1349572

50mg tablet

Trial Locations (1)

90630

GSK Investigational Site, Cypress

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (2)

Shionogi
GlaxoSmithKline
All Listed Sponsors
collaborator

Shionogi

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY